Canada Pension Plan Investment Board’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-10
Closed 1328
2022
Q2
$0 Hold
10
﹤0.01% 1409
2022
Q1
$0 Hold
10
﹤0.01% 1636
2021
Q4
$0 Hold
10
﹤0.01% 1660
2021
Q3
$0 Hold
10
﹤0.01% 1489
2021
Q2
$0 Hold
10
﹤0.01% 1413
2021
Q1
$0 Hold
10
﹤0.01% 1592
2020
Q4
$0 Hold
10
﹤0.01% 1486
2020
Q3
$0 Sell
10
-2,290
-100% -$2.35K ﹤0.01% 1409
2020
Q2
$2K Hold
2,300
﹤0.01% 1364
2020
Q1
$2K Hold
2,300
﹤0.01% 1268
2019
Q4
$2K Hold
2,300
﹤0.01% 1399
2019
Q3
$2K Hold
2,300
﹤0.01% 1168
2019
Q2
$4K Hold
2,300
﹤0.01% 1210
2019
Q1
$4K Buy
+2,300
New +$3.37K ﹤0.01% 1471
2015
Q3
Sell
-1,100
Closed -$12K 1305
2015
Q2
$12K Buy
+1,100
New +$14.1K ﹤0.01% 1256

Other funds holding INFI

Canada Pension Plan Investment Board's INFI Position: Q3 2022 in Review

Canada Pension Plan Investment Board sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2022, closing a stake of 10 shares.

Canada Pension Plan Investment Board first reported a position in INFI in Q2 2015 and held it in 15 quarters. The position peaked at $12K in Q2 2015. 76 funds tracked by Wall St. Rank hold INFI as of Q3 2022.

  • Canada Pension Plan Investment Board reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2022 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 10 Infinity Pharmaceuticals, Inc. shares in Q3 2022.
  • Canada Pension Plan Investment Board first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2015 and held it in 15 quarters.
  • Canada Pension Plan Investment Board's Infinity Pharmaceuticals, Inc. position peaked at $12K in Q2 2015.
  • 76 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2022.

Based on Canada Pension Plan Investment Board's 13F filing for Q3 2022, filed 14 Nov 2022.